CBER Director Peter Marks

Take-homes from new FDA NEJM stem cell piece including surprises

Peter-Marks-Scott-Gottlieb-FDA

FDA Commissioner Scott Gottlieb and CBER Director, Peter Marks, have just published a new piece on stem cells and regenerative medicine in the New England Journal of Medicine (NEJM). What are the core points here and what can we learn from reading between the lines a bit? There are some expected things and then some …

Take-homes from new FDA NEJM stem cell piece including surprises Read More »

FDA Issues 1st Stem Cell Warning Letter of 2018 to American CryoStem

SVF2

The FDA started off 2018 with a bang on the direct-to-consumer stem cell clinic front with a warning letter on January 3rd to American CryoStem, a firm involved in processing and distributing adipose stem cells. The company’s ATCELL™ adipose stem cell product was the focus of much of letter. The FDA indicated in the warning …

FDA Issues 1st Stem Cell Warning Letter of 2018 to American CryoStem Read More »

US Stem Cell bid for FDA RMAT rejected?

US-Stem-Cell-Inc.-e1498151180952

Can a stem cell clinic business get FDA RMAT designation? At least one announced it was trying, but now seems to have given up. Stem cell clinic business US Stem Cell, Inc. has reportedly announced that it is at least temporarily abandoning its efforts at getting Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA. The …

US Stem Cell bid for FDA RMAT rejected? Read More »